Glínski B, Reinfuss M, Walasek T, Skolyszewski J
Service de radiothérapie, institut oncologique, Cracovie, Pologne.
Bull Cancer Radiother. 1996;83(3):177-9.
Two-hundred and fifty patients presenting with a stage I-II cancer of the supraglottic larynx were definitively treated with irradiation. The 5-year disease-free survival rate is 76%. Multivariate analysis reveals that the only statistically significant prognostic parameters are clinical stage (I versus II), and tumour site (epilarynx versus supraglottis).
250例声门上喉I-II期癌症患者接受了根治性放疗。5年无病生存率为76%。多因素分析显示，唯一具有统计学意义的预后参数是临床分期（I期与II期）和肿瘤部位（喉上部与声门上区）。
